Immunogenicity of Del19 EGFR mutations in Chinese patients affected by lung adenocarcinoma

BACKGROUND: Mutant peptides presented by cancer cells are superior vaccine candidates than self peptides. The efficacy of mutant K-Ras, P53 and EGFR (Epidermal Growth Factor Receptor) peptides have been tested as cancer vaccines in pancreatic, colorectal, and lung cancers. The immunogenicity of EGFR...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Deng, Zhou, Dapeng, Cai, Weijing, Wu, Weibo, Tan, Wen Ling, Zhou, Caicun, Lou, Yanyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854806/
https://www.ncbi.nlm.nih.gov/pubmed/31722672
http://dx.doi.org/10.1186/s12865-019-0320-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854806/
https://www.ncbi.nlm.nih.gov/pubmed/31722672
http://dx.doi.org/10.1186/s12865-019-0320-1

Ejemplares similares